Statins in stroke prevention: what an internist should know

Area of Science:

• Cardiovascular Medicine
• Neurology
• Pharmacology

Background:

• The link between high cholesterol (hypercholesterolemia) and stroke has been historically debated, unlike its clearer association with coronary heart disease.
• Epidemiological studies often showed weak correlations between cholesterol levels and stroke incidence, contributing to the controversy.
• Recent clinical evidence increasingly supports statin therapy's efficacy in stroke risk reduction.

Purpose of the Study:

• To review the current evidence on the role of statins in preventing strokes.
• To highlight the impact of statins on stroke risk, including in patients with normal cholesterol levels.
• To emphasize the need for improved stroke risk factor management in clinical practice.

Main Methods:

• Review of recent, long-term clinical studies and large-scale analyses.
• Analysis of data from over 90,000 individuals to quantify the effect of LDL cholesterol reduction on stroke risk.
• Examination of both lipid-lowering and non-lipid (pleiotropic) mechanisms of statin action.

Main Results:

• Statin therapy demonstrably reduces stroke risk, even in patients with normocholesterolemia.
• A 10% decrease in low-density lipoprotein (LDL) cholesterol concentration is associated with a 15.6% reduction in stroke risk.
• Both direct LDL cholesterol reduction and pleiotropic effects contribute to statins' beneficial impact on stroke prevention.

Conclusions:

• Statins are effective in stroke prevention, with benefits extending beyond lipid reduction.
• There is significant potential for improving stroke risk factor management by integrating current knowledge on statin therapy.
• Clinicians, particularly internists, should incorporate these findings into daily practice to enhance patient care and reduce stroke incidence.